Skip to main content
SpringerLink
Log in

Comparative study of inhibitory effects by murine interferon γ and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK)

  • Original Articles
  • Interferon γ, Hypercalcemia, Bisphosphonate, Bone-Resorption, Parathyroid Hormone-Related Protein
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The inhibitory effect of murine interferon γ (muIFNγ) on humoral hypercalcemia in nude mice bearing lower-jaw cancer (LJC-1-JCK), in which parathyroid-hormone(PTH)-related protein is responsible for causing humoral hypercalcemia by activating bone resorption, was examined in comparison with that of a new bisphosphonate, 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (alendronate), muIFNγ was injected into tumor-bearing nude mice for 5 days before the establishment of hypercalcemia. The increase of plasma calcium concentration was delayed and this effect continued for more than 6 days even after the injection was stopped. Alendronate markedly suppressed hypercalcemia in tumor-bearing nude mice but this inhibitory effect continued for less than 6 days. Neither muIFNγ nor alendronate affected the tumor volume or serum PTH-related protein concentration. Injection of muIFNγ into mice for 3 days almost completely abolished the formation of multinucleated osteoclast-like cells from bone marrow cells in vitro, whereas injection of alendronate into mice had no effect. These findings suggested that muIFNγ suppressed the formation of osteoclasts, resulting in the prolonged decrease of plasma calcium concentration in hypercalcemic tumor-bearing nude mice, whereas alendronate is cytotoxic to functionally mature osteoclasts and inhibited osteoclastic bone resorption, resulting in a marked decrease in the plasma calcium concentration in tumor-bearing hypercalcemic nude mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mundy GR (1988) Hypercalcemia of malignancy revisited. J Clin Invest 82: 1

    PubMed  Google Scholar 

  2. Stewart AF, Broadus AE (1990) Humoral hypercalcemia of malignancy. Adv Endocrinol Metab 1: 1

    Google Scholar 

  3. Broadus AE, Mangin M, Ikeda K, Isogna KL, Weir EC, Burtis WJ, Stewart AF (1988) Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide. N Engl J Med 319: 556

    PubMed  Google Scholar 

  4. Sato K, Fujii Y, Kasono K, Ozawa M, Imamura H, Kanaji Y, Kurosawa H, Tsushima T, Shizume K (1989) Parathyroid hormone-related protein and interleukin-1α synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology 124: 2172

    PubMed  Google Scholar 

  5. Fukumoto S, Matsumoto T, Harada S, Fujisaki J, Kawano M, Ogata E (1991) Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production. J Clin Endocrinol Metab 73: 877

    PubMed  Google Scholar 

  6. Yoneda T, Alsina MA, Chavez JB, Bonewald L, Nishimura R, Mundy GR (1991) Evidence that tumor necrosis factor plays a pathogenic role in the parancoplastic syndromes of eachexia, hypercalcemia and leukocytosis in a human tumor in nude mice. J Clin Invest 87: 977

    PubMed  Google Scholar 

  7. Sabatini M, Yates AJP, Garrett IR, Charez J, Dunn JF, Bonewald L, Mundy GR (1990) Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy. Lab Invest 63: 676

    PubMed  Google Scholar 

  8. Mundy GR (1990) Malignancy and hypercalcemia. In: Mundy GR (ed) Calcium homeostasis: hypercalcemia and hypocalcemia. Martin Dunitz, London, p 69

    Google Scholar 

  9. Mundy GR (1990) Treatment of hypercalcemia due to malignancy. In: Mundy GR (ed) Calcium homeostasis: hypercalcemia and hypocalcemia. Martin Dunitz, London p 16

    Google Scholar 

  10. Fleisch H, Russell RGG, Francis MD (1969) Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 165: 1262

    PubMed  Google Scholar 

  11. Fleisch H, Felix R (1979) Diphosphonate. Calcif Tissue Int 27: 91

    PubMed  Google Scholar 

  12. Fleisch H (1983) Bisphosphonate: mechanism of action and clinical application. In: Pech WA (ed) Bone and mineral research. Excerpta Medica, Amsterdam, p 319

    Google Scholar 

  13. Jung A, Menmillod B, Barras C, Baud M, Courvoisier B (1981) Inhibition by two diphosphonates of bone lysis in tumour-conditioned media. Cancer Res 41: 3233

    PubMed  Google Scholar 

  14. Jung A, Bomand J, Memillod B, Edouard C, Meunier PJ (1984) Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Res 44: 3007

    PubMed  Google Scholar 

  15. Abe T, Kawamuki K, Kudo M, Ouchi N, Isomura Y, Takeuchi M, Sakamoto S, Murase K, Kawashima H (1089) Biological activity of a new bisphosphonate, YM-084, in animals. J Bone Miner Res 4 [Suppl 1]: S539

    Google Scholar 

  16. Nemoto, R, Nishijima K, Uchida K, Koiso K (1993) Inhibition by a new bisphosphonate (YM-175) of bone resorption induced by the MBT-2 tumour of mice. Br J Cancer 67: 893

    PubMed  Google Scholar 

  17. Peterlik M, Hoffmann O, Swetly P, Kraushofer K, Koller K (1985) Recombinant γ interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria. FEBS Lett 188: 287

    Google Scholar 

  18. Gowen M, Nedwin GE, Mundy GR (1986) Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J Bone Miner Res 1: 469

    PubMed  Google Scholar 

  19. Sato K, Satoh T, Shimizu K, Yamanaka Y, Ono Y, Demura H, Arai T, Takahashi N, Suda T (1992) Prolonged decrease of serum calcium concentration by murine γ-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice. Cancer Res 52: 444

    PubMed  Google Scholar 

  20. Gowen M, Mundy GR (1986) Action of recombinant interleukin 1, interleukin 2, and interferon-γ on bone resorption in vitro. J Immunol 136: 2478

    PubMed  Google Scholar 

  21. Takahashi N, Mundy GR, Roodman GR (1986) Recombinant human interferon γ inhibits formation of human osteoclast-like cells. J Immunol 137: 3544

    PubMed  Google Scholar 

  22. Asano S, Urabe A, Okabe T, Sato N, Kondo Y, Yeyama Y, Chiba S, Ohsawa N, Kosaka K (1977) Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumour tissue. Blood 49: 845

    PubMed  Google Scholar 

  23. Kondo Y, Sato K, Ohkawa H, Ueyama Y, Okabe T, Sato N, Asano S, Mori M, Ohsawa N, Kosaka K (1983) Association of hypercalcemia with tumors producing colony-stimulating factor(s). Cancer Res 43: 2368

    PubMed  Google Scholar 

  24. Katoh Y, Nakamura M, Ohnishi Y, Shimamura K, Ueyama Y, Tamaoki N (1993) Autonomous production of granulocyte-colony stimulating factor in tumour xenografts associated with leukocytosis. Br J Cancer 68: 715

    PubMed  Google Scholar 

  25. Nagata K, Kikuchi N, Ohara O, Teraoka H, Yoshida N, Kawade Y (1986) Purification and characterization of recombinant murine immune interferon. FEBS Lett 205: 200

    PubMed  Google Scholar 

  26. Mario JJ, de Carli LL (1962) Phosphatase variants in a heteroploid strain of human cells in tissue culture. Nature 196: 600

    Google Scholar 

  27. Takahashi N, Akatsu T, Sasaki T, Nicholson GC, Mosely JM, Martin TJ, Suda T (1988) Induction of calcitonin receptors by 1α,25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123: 1504

    PubMed  Google Scholar 

  28. Flanagan AM, Chambers TJ (1989) Dichloromethylenebis-phosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorp Cl2MBP-coated bone. Bone Miner 6: 33

    PubMed  Google Scholar 

  29. Boonekamp PM, Wee-Pals van der, Wik-van Lennep MML van, Thesing CW, Bijvoet OLM (1986) Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1: 27

    PubMed  Google Scholar 

  30. Lowik CWGM, Pluijm G van der, Wee-Pals LJA van der, Bloys van Treslong-de Groot H, Bijvoet OLM (1988) Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effects of a bisphosphonate. J Bone Miner Res 3: 185

    PubMed  Google Scholar 

  31. Nanes MS, Mckoy WM, Marx SJ (1989) Inhibitiory effects of tumor necrosis factor-α and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8) Endocrinology 124: 339

    PubMed  Google Scholar 

  32. Smith DD, Gowen M, Mundy GR (1987) Effects of interferon-γ and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120: 2494

    PubMed  Google Scholar 

  33. Nanes M, Rubin J, Titus L, Hendy GN, Catherwood BD (1990) Interferon-γ inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism. Endocrinology 127: 588

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shionogi Research Laboratories, Shionogi & Co. Ltd., Fukushima-ku 12-4, Sagisu 5-chome, 553, Osaka, Japan

    Masahiro Tohkin, Shinji Kakudo, Hisashi Kasai & Hitoshi Arita

Authors
  1. Masahiro Tohkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shinji Kakudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hisashi Kasai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hitoshi Arita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tohkin, M., Kakudo, S., Kasai, H. et al. Comparative study of inhibitory effects by murine interferon γ and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK). Cancer Immunol Immunother 39, 155–160 (1994). https://doi.org/10.1007/BF01533380

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01533380

Key words

Search

Navigation